DK2068842T3 - Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf - Google Patents

Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf

Info

Publication number
DK2068842T3
DK2068842T3 DK07802308.2T DK07802308T DK2068842T3 DK 2068842 T3 DK2068842 T3 DK 2068842T3 DK 07802308 T DK07802308 T DK 07802308T DK 2068842 T3 DK2068842 T3 DK 2068842T3
Authority
DK
Denmark
Prior art keywords
tmdc
moisture
dosage form
trimagnesium
desiccant
Prior art date
Application number
DK07802308.2T
Other languages
English (en)
Other versions
DK2068842T4 (da
Inventor
Peter Gruber
Dirk Spickermann
Original Assignee
Losan Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37944541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2068842(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Losan Pharma Gmbh filed Critical Losan Pharma Gmbh
Application granted granted Critical
Publication of DK2068842T3 publication Critical patent/DK2068842T3/da
Publication of DK2068842T4 publication Critical patent/DK2068842T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07802308.2T 2006-09-25 2007-09-14 Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf DK2068842T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06020008A EP1902708A1 (de) 2006-09-25 2006-09-25 Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
PCT/EP2007/008006 WO2008037359A2 (de) 2006-09-25 2007-09-14 Wirkstoff enthaltende stabilisierte feste arzneimittelformen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
DK2068842T3 true DK2068842T3 (da) 2010-05-31
DK2068842T4 DK2068842T4 (da) 2015-10-26

Family

ID=37944541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07802308.2T DK2068842T4 (da) 2006-09-25 2007-09-14 Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf

Country Status (8)

Country Link
US (5) US9775807B2 (da)
EP (2) EP1902708A1 (da)
AT (1) ATE459342T1 (da)
AU (1) AU2007302320A1 (da)
CA (1) CA2663941C (da)
DE (1) DE502007003037D1 (da)
DK (1) DK2068842T4 (da)
WO (1) WO2008037359A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006226293B2 (en) 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
EP1902708A1 (de) * 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
KR101643219B1 (ko) * 2011-10-06 2016-07-27 노파르티스 아게 40-o-(2-히드록시)에틸-라파마이신을 포함하는 제약 조성물
EA201792314A1 (ru) 2015-05-20 2018-05-31 Новартис Аг Фармацевтическая комбинация эверолимуса и дактолисиба
CN110114070A (zh) 2016-11-23 2019-08-09 诺华公司 使用依维莫司(everolimus)、达托里昔布(dactolisib)或二者增强免疫反应的方法
US10596165B2 (en) 2018-02-12 2020-03-24 resTORbio, Inc. Combination therapies
WO2022182778A1 (en) * 2021-02-24 2022-09-01 Nostrum Pharmaceuticals, Llc Pharmaceutical packages and methods of reducing formation of n-nitrosodimethylamine

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
FR2670675B1 (fr) 1990-12-20 1993-04-16 Lafon Labor Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels.
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
FR2698788B1 (fr) 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
JPH06277431A (ja) 1993-03-31 1994-10-04 Motoda Electron Co Ltd 気体の吸引濾過装置
FR2709961B1 (fr) 1993-09-14 1995-12-08 Lafon Labor Forme pharmaceutique moulée pour administration orale à base d'acide acétylsalicylique ou de ses sels et son procédé de fabrication.
FR2712809B1 (fr) † 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
JP3574185B2 (ja) 1994-09-02 2004-10-06 小松屋化学株式会社 無水クエン酸トリマグネシウムおよびその製法
CH687615A5 (de) * 1994-09-07 1997-01-15 R W Johnson Pharmaceutical Res Tropen-Verpackung.
EP0712790B1 (de) * 1994-11-15 1999-02-03 Alusuisse Technology & Management AG Blisterpackung
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
GB9721397D0 (en) 1997-10-09 1997-12-10 Verdugt Bv Anticaking agents
DE19962251A1 (de) * 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lutschtablette
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
CN1615135A (zh) * 2001-11-13 2005-05-11 法马西亚公司 磺酰胺前药如帕瑞考昔的口服剂型
DE10230752A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis von Magnesiumsalzen und Fibrinolytika
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
JP6521564B2 (ja) * 2010-12-22 2019-05-29 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 速崩性の固体被覆剤形

Also Published As

Publication number Publication date
EP2068842B2 (de) 2015-09-23
EP2068842B1 (de) 2010-03-03
CA2663941C (en) 2014-12-30
AU2007302320A1 (en) 2008-04-03
EP1902708A1 (de) 2008-03-26
DE502007003037D1 (de) 2010-04-15
US20200188303A1 (en) 2020-06-18
US20220000785A1 (en) 2022-01-06
WO2008037359A3 (de) 2008-06-26
US10603280B2 (en) 2020-03-31
US10206879B2 (en) 2019-02-19
US20190105273A1 (en) 2019-04-11
DK2068842T4 (da) 2015-10-26
US9775807B2 (en) 2017-10-03
US20090270515A1 (en) 2009-10-29
CA2663941A1 (en) 2008-04-03
WO2008037359A2 (de) 2008-04-03
ATE459342T1 (de) 2010-03-15
EP2068842B9 (de) 2010-08-11
US20180000739A1 (en) 2018-01-04
EP2068842A2 (de) 2009-06-17

Similar Documents

Publication Publication Date Title
DK2068842T4 (da) Aktivt stof og trimagnesiumdicitrat som stabiliserede faste lægemiddelformer, der indeholder tørremiddel, og fremgangsmåde til fremstilling deraf
CN102038648B (zh) 治疗消化性溃疡的粉针剂及其制备方法
NO20072739L (no) Stabiliserte ramiprilsammensetninger og fremgangsmater for fremstilling
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
CN1946380A (zh) 口腔崩解制剂及其制备方法
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
NO20052011L (no) Oralt veterinaer medikament leveringssystem og/eller fortilsetningsmiddel leveringssystem, fremgangsmate for fremstilling og anvendelse derav
CN111529493A (zh) 一种易溶于水且稳定性高的阿莫西林可溶性粉及其制备方法
CN100408032C (zh) 一种稳定的多西他赛注射剂
RU2333000C2 (ru) Фармацевтические составы, обладающие антибиотической активностью
PL1765342T3 (pl) Kompozycja farmaceutyczna zawierająca besylan amlodypiny i dihydrat lizynoprylu oraz sposób jej wytwarzania
JP2022542304A (ja) ブルシンゲル製剤及びその製造方法
BR112015021630A2 (pt) estabilização de fármacos sensíveis à umidade
CN105456264B (zh) 双效缓泻的药物组合物及其制备方法
EA200701805A1 (ru) Состав аэрозоля для дозирующих ингаляторов под давлением
WO2007103931A3 (en) Nanofluidized b-12 composition and process for treating pernicious anemia
CN101869545B (zh) 包埋型的载药葡甘聚糖与黄原胶复合凝胶的制备方法
WO2008143144A1 (ja) 澱粉含有組成物及びその製造方法
WO2008033058A3 (fr) Procédé permettant de produire une préparation d'insuline pour administration orale
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
CA2532714A1 (en) Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
CY1108846T1 (el) Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της
WO2009050555A3 (fr) Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations
Kolli et al. Formulation and evaluation of matrix tablet of ramipril